merck & co. inc. (6MK:Frankfurt)
Peter N. Kellogg BSE, MBA
Chief Financial Officer and Executive Vice President, Celgene Corporation
|Age||Total Calculated Compensation||This person is connected to 17 board members in 2 different organizations across 6 different industries.|
See Board Relationships
Mr. Peter N. Kellogg, BSE, MBA has been an Executive Vice President at Celgene Corporation since July 2014 and its Chief Financial Officer since August 1, 2014. Mr. Kellogg served as Executive Vice President of Merck & Co. Inc. from August 14, 2007 to May 16, 2014 and served as its the Chief Financial Officer from August 14, 2007 to April 23, 2014. He served as the Chief Financial Officer and Executive Vice President of Finance at Biogen Idec Inc. since November 2003 ...
One Merck DrivePhone: 908-423-1000
Whitehouse Station, New Jersey 08889
Board Members Memberships*
Former Chief Financial Officer and Executive Vice President
Director and Member of Audit Committee
The University of Pennsylvania
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Lamberto Andreotti||Chief Executive Officer, Director, Member of Executive Committee and Member of Securities Issuance Committee|
Bristol-Myers Squibb Company
|George A. Scangos Ph.D.||Chief Executive Officer and Director|
Biogen Idec Inc.
|Marc N. Casper||Chief Executive Officer, President, Director, Member of Strategy & Finance Committee and Member of Science & Technology Committee|
Thermo Fisher Scientific, Inc.
|John C. Lechleiter Ph.D.||Chairman, Chief Executive Officer and President|
Eli Lilly and Company
|Flemming Ornskov M.D., MBA, MPH||Chief Executive Officer, Managing Director and Director|
|$2.7M||Compensation as of Fiscal Year 2013.|